Glanbia targets group revenue of over €5 billion by 2022

Glanbia's group managing director Siobhan Talbot
Glanbia's group managing director Siobhan Talbot

Glanbia outlined its group ambitions at the company’s Capital Markets Day in its US “innovation center” in Illinois.

The event was held yesterday (Wednesday, May 23) beginning at 8:00am and running through until 6:00pm local time.

The group gave a breakdown of its 2018 full year guidance, as well as an outline of its five-year financial ambition – targeting revenue growth of 38% by the end of 2022.

Commenting at the event, Siobhan Talbot, group managing director of Glanbia said: “I’m very pleased to host our 2018 Capital Markets Day at our innovation center in Downers Grove, Illinois.

Over the course of the event, my colleagues and I will outline our ambition to grow total group revenue from €3.6 billion, pro forma, in 2017 to over €5 billion by 2022.

“Glanbia is today a focused group with market leading platforms in performance nutrition, value-added nutritional solutions and dairy ingredients,” she added.

“We are well positioned to capture growth from global consumer nutrition trends related to health and wellness, active lifestyles and clean ingredients.”

Glanbia Group – with its three platforms of Glanbia Performance Nutrition, Glanbia Nutritionals and Strategic Joint Ventures – is positioned to deliver long-term sustainable growth, the company claims.

This will be enabled by organic growth and selective mergers and acquisitions, according to the dairy giant.

With a “strong balance sheet”, the group says it has the capacity to fund future growth opportunities.

Meanwhile, as revealed by Glanbia last week in its milk price announcement, the processor has introduced new measures for co-op members and suppliers.

Chairman Henry Corbally said: “We are acutely conscious that adverse weather has made 2018 a very challenging year to date for our milk suppliers. As a result, the board has made a number of decisions that will boost cash flow for members.”

Topics

Share this article